3billion
3billion, Inc. develops technology for rare disease drug discovery using bioinformatics and machine learning technology. The company focuses on developing methods for novel drug target discovery, drug candidate generation, and safety assessment. It offers genetic and biomolecular testing services related to the analysis of biologic samples of patients suspected to have rare genetic disorders, as … Read more
3billion (394800) - Total Liabilities
Latest total liabilities as of March 2025: ₩5.89 Billion KRW
Based on the latest financial reports, 3billion (394800) has total liabilities worth ₩5.89 Billion KRW as of March 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
3billion - Total Liabilities Trend (2021–2024)
This chart illustrates how 3billion's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
3billion Competitors by Total Liabilities
The table below lists competitors of 3billion ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
I.Ceram SA
PA:ALICR
|
France | €3.48 Million |
|
DRAX GROUP
BE:D9F2
|
Germany | €4.06 Billion |
|
United Breweries Co Inc
STU:CVU
|
Germany | €2.07 Trillion |
|
Lithos Energy Ltd.
OTCQB:LITSF
|
USA | $3.61 Million |
|
Star Alliance International Corp
PINK:STAL
|
USA | $2.70 Million |
|
ChampionsGate Acquisition Corporation Class A Ordinary Share
NASDAQ:CHPG
|
USA | $1.62 Million |
|
Digital Bros SpA
STU:DB7
|
Germany | €107.29 Million |
Liability Composition Analysis (2021–2024)
This chart breaks down 3billion's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 9.49 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | 4.10 | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.22 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.18 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how 3billion's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for 3billion (2021–2024)
The table below shows the annual total liabilities of 3billion from 2021 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | ₩1.94 Billion | -82.43% |
| 2023-12-31 | ₩11.07 Billion | -2.42% |
| 2022-12-31 | ₩11.35 Billion | +504.85% |
| 2021-12-31 | ₩1.88 Billion | -- |